These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6488437)

  • 1. Pharmacological studies of ricin in mice and humans.
    Godal A; Fodstad O; Ingebrigtsen K; Pihl A
    Cancer Chemother Pharmacol; 1984; 13(3):157-63. PubMed ID: 6488437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity, distribution and elimination of the cancerostatic lectins abrin and ricin after parenteral injection into mice.
    Fodstad O; Olsnes S; Pihl A
    Br J Cancer; 1976 Oct; 34(4):418-25. PubMed ID: 974006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo reconstitution of ricin-like activity from its A and B chain subunits.
    Cushley W; Muirhead MJ; Silva F; Greathouse J; Tucker T; Uhr JW; Vitetta ES
    Toxicon; 1984; 22(2):265-77. PubMed ID: 6729842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of residual toxin in tissues of ricin-poisoned mice by sandwich enzyme-linked immunosorbent assay and immunoprecipitation.
    Men J; Lang L; Wang C; Wu J; Zhao Y; Jia PY; Wei W; Wang Y
    Anal Biochem; 2010 Jun; 401(2):211-6. PubMed ID: 20206120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the plasma clearance of antibody--ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A chain that mediate rapid clearance of the immunotoxin.
    Bourrie BJ; Casellas P; Blythman HE; Jansen FK
    Eur J Biochem; 1986 Feb; 155(1):1-10. PubMed ID: 3948873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of injected 125I-ricin by rat liver in vivo. Subcellular distribution and characterization of the internalized ligand.
    Frénoy JP; Turpin E; Janicot M; Gehin-Fouque F; Desbuquois B
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):249-57. PubMed ID: 1599402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.
    Ito T; Qiu H; Collins JA; Brill AB; Johnson DK; Griffin TW
    Cancer Res; 1991 Jan; 51(1):255-60. PubMed ID: 1988087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of an antibody-ricin A chain conjugate administered to normal rats.
    Worrell NR; Cumber AJ; Parnell GD; Ross WC; Forrester JA
    Biochem Pharmacol; 1986 Feb; 35(3):417-23. PubMed ID: 3947379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice.
    Godal A; Fodstad O; Pihl A
    Int J Cancer; 1983 Oct; 32(4):515-21. PubMed ID: 6618711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical studies on oral toxicity of ricin. IV. A fate of orally administered ricin in rats.
    Ishiguro M; Tanabe S; Matori Y; Sakakibara R
    J Pharmacobiodyn; 1992 Apr; 15(4):147-56. PubMed ID: 1494977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of ricin by colorimetric and chemiluminescence ELISA.
    Poli MA; Rivera VR; Hewetson JF; Merrill GA
    Toxicon; 1994 Nov; 32(11):1371-7. PubMed ID: 7886695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target: pharmacokinetics and biodistribution of two divalent, ricin-based immunotoxins in xenografted athymic mice.
    Faguet GB; Agee JF
    Leuk Lymphoma; 1997 May; 25(5-6):509-20. PubMed ID: 9250822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution.
    Thorpe PE; Detre SI; Foxwell BM; Brown AN; Skilleter DN; Wilson G; Forrester JA; Stirpe F
    Eur J Biochem; 1985 Feb; 147(1):197-206. PubMed ID: 2982609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody-based enzyme immunoassay for detection of ricin.
    Shyu HF; Chiao DJ; Liu HW; Tang SS
    Hybrid Hybridomics; 2002 Feb; 21(1):69-73. PubMed ID: 11991819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody.
    Blakey DC; Watson GJ; Knowles PP; Thorpe PE
    Cancer Res; 1987 Feb; 47(4):947-52. PubMed ID: 3492271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong protection against ricin challenge induced by a novel modified ricin A-chain protein in mouse model.
    Zhang T; Yang H; Kang L; Gao S; Xin W; Yao W; Zhuang X; Ji B; Wang J
    Hum Vaccin Immunother; 2015; 11(7):1779-87. PubMed ID: 26038805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel neutralizing monoclonal antibody against both ricin toxin A and ricin toxin B, and application of a rapid sandwich enzyme-linked immunosorbent assay.
    Guo J; Shen B; Sun Y; Yu M; Hu M
    Hybridoma (Larchmt); 2006 Aug; 25(4):225-9. PubMed ID: 16934019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G; Runge W; Jansen FK; Vallera DA
    Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.